The largest database of trusted experimental protocols

Collagen type 4

Manufactured by BD
Sourced in United States

Collagen type IV is a structural protein component found in the basement membrane of various tissues, including skin, blood vessels, and kidney glomeruli. It functions as a key structural element, providing support and scaffolding for cells within these tissues.

Automatically generated - may contain errors

24 protocols using collagen type 4

1

Cell Invasion Assay with Collagen IV

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell invasion were determined using 24-well microchemotaxis chambers precoated with 7.5 μg collagen type IV (Becton Dickinson Labware), as previously described [57 (link)]. Tumor cells were resuspended in serum-free media and loaded into upper chamber of each well. Cells were incubated at 37°C for 24 h in the presence or the absence of B1f and B3 compounds, after which, the filters were fixed and stained with Diff-Quik (Medion Diagnostic). Cell invasion were quantified by determination of the number of cells that migrated directly through the membrane toward the medium containing 10% serum that was used as a chemoattractant. Cells detected in each well were counted and the results were represented as (number of migrated cells/number of total cells) × 100%.
+ Open protocol
+ Expand
2

Quantification of Cell Migration and Invasion

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell migration and invasion were determined using 24-well microchemotaxis chambers alone or precoated with 7.5 μg collagen type IV (Becton Dickinson Labware), respectively [5 (link), 26 (link)]. Control tumor cells or cells expressing Spn4A cDNA were resuspended in serum-free media and loaded into upper chamber of each well. Cells were incubated at 37°C for 24 h, after which, the filters were fixed and stained with Diff-Quik (Medion Diagnostic). Cell migration and invasion were quantified by determination of the number of cells that migrated directly through the membrane toward the medium containing 10% serum that was used as a chemoattractant. Cells detected in each well were counted and the results were represented as (number of migrated cells/number of total cells) × 100%.
+ Open protocol
+ Expand
3

Isolation and Culture of Rat IMCD Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Inner medullary collecting duct (IMCD) cells were prepared from inner medullas including papilla of sacrificed Wistar rats (license # 84-02.05.20.11.256), as previously described [28 (link)]. Briefly, the inner medullas including papilla of sacrificed Wistar rats were removed, cut into small pieces, and digested in phosphate-buffered saline (PBS) containing 0.2% hyaluronidase (Sigma) and 0.2% collagenase type CLS-II (Sigma) at 37°C for 90 min. Cells were centrifuged at 450 x g, resuspended in PBS and centrifuged once more. Cells were seeded on glass coverslips coated with collagen type IV (Becton-Dickinson) at a density of 105 cells/cm2 and cultured in DMEM containing 100 IU/ml penicillin, 100 μg/ml streptomycin, 0.2% glutamine, 1% nonessential amino acids and 1% ultroser G (BioSepra Inc.) in an 8% CO2 atmosphere.
+ Open protocol
+ Expand
4

In Vitro Invasion Assay of Tumor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The in vitro invasion activity of control and MDA-MB-231 ppFurin-expressing cells was performed using 24-well microchemotaxis chambers precoated with 7.5 μg of collagen type IV (Becton Dickinson Labware, Franklin Lake, NJ, USA), as previously described [22 (link),31 (link)]. Tumor cells (1 × 105/mL) were resuspended in serum-free media and were loaded into the upper chamber of Transwells. Cells were incubated at 37 °C for 24 h, and invasion across collagen layer was initiated by adding 10% FBS (chemoattractant) to the lower chamber. Cells detected in each well were counted and the results were represented as (number of migrated cells/number of total cells) × 100%.
+ Open protocol
+ Expand
5

Cell Invasion Assay with Boyden Chamber

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell invasion was evaluated by a modified Boyden chamber method using a 48-well chemotaxis chamber (NeuroProbe, Gaithersburg, MD). Briefly, 25,000 HepG2 and 20,000 Hep3B cells per well were seeded onto an 8 µM pore PDVF membrane (NeuroProbe) previously treated with collagen type IV (BD Biosciences, San Jose, CA) and conditioned medium from scramble- and siPRPF8-treated cells. The lower well was filled with FBS-free medium (negative control) or medium containing 10% FBS, with two replicates per condition23 (link). After 24 h, the non-migrated cells were removed, and the migrated cells were fixed with crystal violet solution (6% glutaraldehyde, 0.5% crystal violet). Images of random fields were acquired and analyzed with ImageJ. The experiments were performed in triplicate.
+ Open protocol
+ Expand
6

Enrichment and Culture of KDR+ VPC

Check if the same lab product or an alternative is used in the 5 most similar protocols
KDR+ VPC induced from stage were first labeled with biotinylated anti-VEGF-2/KDR+ ((Miltenyi Biotech) followed by Streptavidin MicroBeads (Miltenyi Biotech), and processed through a MACS magnetic separation column (Miltenyi Biotech) according to the manufacturer recommendations. The KDR+ VPC were plated on dishes coated with either: 10 ng/ml fibronectin (BD Biosciences), 50ng/ml collagen-type IV (BD Biosciences), or 0.5% gelatin at either: 5,000, 10,000, or 20,000 cells/cm2. The stage 2 medium consisted of: 70% alpha-MEM and 30% DMEM, 2Χ Nutridoma CS, 1Χ ps, 1Χ NEAA, 2 mM L-glutamine, and 0.05 mM 2-mercaptoethanol. The supplemental amounts of bFGF examined included: 0 ng/ml, 10 ng/ml, 25 ng/ml, or 50 ng/ml; while amounts of VEGF examined were: 0 ng/ml, 10 ng/ml, 25 ng/ml, or 50 ng/ml. Half media changes were performed every 3 days. The cells were collected 2 weeks following the stage 1 induction, at days 28 and 26 of total differentiation for H7-ESC and H9-ESC, respectively.
+ Open protocol
+ Expand
7

Shear Stress Differentiation of Pluripotent Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pluripotent cells were differentiated in medium without LIF and exposed to shear stress, as described previously [13 (link),19 (link)]. As in those studies, glass slides were coated with collagen type IV (3.5 μg/cm2; BD Biosciences, Bedford, MA) for one hour. ESCs and iPSCs were then seeded onto slides at 10,000 cells/cm2 and 40,000 cells/cm2, respectively, to generate similar cell densities just prior to the application of shear. All samples were cultured for two days in differentiation medium (Minimum Essential Alpha Media, 10% fetal bovine serum, 0.1 mM beta-mercaptoethanol, and antibiotics). Fluid flow was applied to cells on slides using a parallel plate bioreactor system, in which medium was recirculated through a flow chamber with a defined channel geometry. Using a calibrated flow rate, a steady laminar shear stress of 5.0 dynes/cm2 was applied for two days (SHEAR). Control samples (STATIC) were cultured under the same time and volume conditions. SHEAR and STATIC samples were imaged and analyzed for gene expression of cytoskeletal proteins.
+ Open protocol
+ Expand
8

Directed Differentiation of mESCs to Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mESC (A3 and R1 lines) were harvested using trypsin/EDTA (Mediatech) and plated with either 50 ng/mL collagen-type IV (BD Biosciences) or 50 ng/mL fibronectin (BD Biosciences) in basal medium: alpha-minimal essential medium (MEM; Cellgro), 20% KSR (Invitrogen), 1Χ penicillin-streptomycin (ps, Invitrogen), 1Χ nonessential amino acids (NEAA; Invitrogen), 2 mM L-glutamine (Invitrogen), 0.05mM 2-mercaptoethanol (Calbiochem), and 5 ng/mL BMP-4 (R&D Systems), supplemented with either 0 ng/mL, 10 ng/mL, 20 ng/mL, or 30 ng/mL of VEGF (R&D Systems) and induced for between 1–4 days. Experiments were repeated in triplicate (N = 3).
+ Open protocol
+ Expand
9

In vitro Rat Blood-Brain Barrier Co-Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary rat brain microvascular endothelial cells (BMEC) and primary astrocytes necessary for setting up a rat in vitro BBB co-culture model were obtained as reported (Molino et al.65 ,66 (link). Briefly, primary cultures of BMECs, from 5- to 6-week-old Wistar rats, were seeded in the luminal compartment of twelve-well plate polyethylene insert filters (Merck Millipore, Billerica, MA, USA), pre-coated with collagen type IV and fibronectin (BD Biosciences, Franklin Lakes, NJ, USA) to establish the endothelial cell monolayers. Astrocyte primary cultures were prepared from the cerebral cortex of newborn Wistar rats and seeded in the bottom of the twelve-well plates to establish the co-culture with the endothelial cell monolayers in endothelial cell media (ECM) containing DMEM/F12 supplemented with 20% bovine platelet poor plasma derived serum (Alfa Aesar, Ward Hill, MA, USA), basic fibroblast growth factor (bFGF) 2 ng/mL, heparin 100 μg/ mL, gentamycin 50 μg/mL, HEPES 2.5 mM, and hydrocortisone 500 nM (Life Technologies, Carlsbad, CA, USA). Under these conditions, the BMEC monolayers differentiate, express junction-related proteins within 3 days, and remain optimally differentiated during three more days.
+ Open protocol
+ Expand
10

Breast Cell Morphology and Peroxisome Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
Normal HME cells were obtained from Lonza (Walkersville, MD). Tumorigenic non-metastatic human mammary epithelial (HMLER) cells developed in the Weinberg laboratory (Elenbaas et al. 2001 (link)) were provided by Karin Scarpinato. Metastatic HME (MDA-MB-231) cells were obtained from the American Type Culture Collection (ATCC, Manassas, VA). Normal, tumorigenic, and metastatic breast cells were cultured in mammary epithelial growth medium (MEGM) supplemented with 0.4% bovine pituitary extract (Lonza) at 37 °C with 5% CO2. Two or three days before imaging, either 80,000 (normal and metastatic) or 160,000 (tumorigenic) cells were plated in 35-mm glass-bottom dishes (WillCo Wells, Amsterdam). The dishes were coated with 100 μl of a 33 μg/ml collagen type IV (BD Biosciences, Franklin Lakes, NJ), 67 μg/ml laminin mixture (Engelbreth-Holm-Swarm murine sarcoma, Sigma-Aldrich, St Louis, MO) to mimic the composition of a basement membrane. To fluorescently label peroxisomes with GFP, 10 μl BacMam 2.0 peroxisome-GFP reagent (Life Technologies, Carlsbad, CA) was added to each dish 1day before imaging. Figure 2 shows the morphologies of individual normal, tumorigenic and metastatic cells and the distribution of GFP-labeled peroxisomes.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!